하스
Financials
Valuation Metrics
하스's Market Cap is ₩339B. At end of 2025 it was ₩513B. Ranked #1986 of 2,436 in KR market (top 82%), #1251 of 1,649 on KOSDAQ (top 76%), #83 of 96 in Health Care Equipment & Services (top 86%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 33.93B KRW | KR#1,986/2,436 Sec#83/96 |
| Revenue | 16.58B KRW | KR#2,184/2,436 Sec#73/96 |
| Net Income | 1.41B KRW | KR#1,401/2,436 Sec#44/96 |
| Total Assets | 51.63B KRW | KR#2,177/2,436 Sec#74/96 |
| Net Assets | 42.51B KRW | KR#1,983/2,436 Sec#68/96 |
| Employees | 102 | KR#1,612/2,436 Sec#56/96 |
| Value | ||
| P/E | 24.10x | KR#1,176/2,436 Sec#36/96 |
| P/B | 0.80x | KR#1,282/2,436 Sec#23/96 |
| P/S | 2.05x | KR#1,831/2,436 Sec#50/96 |
| EV/EBITDA | 47.79x | KR#1,336/2,436 Sec#43/96 |
| FCF Yield | -0.46% | KR—/2,436 Sec—/96 |
| Profitability | ||
| ROE | 3.31% | KR#1,197/2,436 Sec#43/96 |
| ROA | 2.73% | KR#994/2,436 Sec#39/96 |
| Op. Margin | 4.71% | KR#963/2,436 Sec#41/96 |
| Revenue Growth | -0.46% | KR#1,470/2,436 Sec#64/96 |
| Earnings Growth | -7.38% | KR#966/2,436 Sec#38/96 |
| Financial Health | ||
| Debt Ratio | 121.45% | KR#689/2,436 Sec#32/96 |
| Total Debt | 6.36B KRW | KR#1,735/2,436 Sec#60/96 |
| FCF | -155.4M KRW | KR#1,232/2,436 Sec#34/96 |
| Cash | 3.02B KRW | KR#2,153/2,436 Sec#85/96 |
| Current Ratio | 3.22x | KR#561/2,436 Sec#34/96 |
| Net Debt/EBITDA | 4.29x | KR#1,038/2,436 Sec#42/96 |
| Dividend | ||
| Div. Yield | 1.51% | KR#1,027/2,436 Sec#31/96 |
| Div. Growth | -14.29% | KR—/2,436 Sec—/96 |
| Performance | ||
| 1Y Return | -44.44% | KR#1,947/2,436 Sec#70/96 |
| 1M Return | -21.05% | KR#2,226/2,436 Sec#87/96 |
| From 52W High | -52.36% | KR#1,313/2,436 Sec#50/96 |
| 1Y MDD | -53.09% | KR#1,063/2,436 Sec#36/96 |
| Trading | ||
| Volume | 3,158 shares | KR#2,313/2,436 Sec#93/96 |
| Foreign Own. | 1.06% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | 174 KRW | KR#1,248/2,436 Sec#41/96 |
| BPS | 5,435 KRW | KR#1,376/2,436 Sec#35/96 |
Company Info
Haas, established in 2008 and headquartered in Gangneung-si, Gangwon Special Self-Governing Province, is a dental restorative material manufacturer. The company produces lithium disilicate crystallized glass and zirconia materials based on nano-crystallization technology, listing on KOSDAQ in 2024. It has successfully developed and mass-produced dental prosthetic restorative materials using lithium silicate-based crystallized glass, selling its Amber and Rosetta brands worldwide. Haas is expanding its global consumer base through diverse product lines and the development of high-strength aesthetic materials.